An Exosomal mRNA Urine Test for Detection and Risk Stratification of Human Kidney Transplant Rejection

Exosomal mRNA gene signatures identified patients with different stages and classes of rejection, including early stage and significant inflammation, enabling improved decision-making and patient management and reducing unnecessary biopsies by 45%. This represents a potential tool for risk stratification based on poor outcomes in patients with positive signatures.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2025-02-03
DOI
https://doi.org/10.1016/j.ekir.2025.01.036
Citations
7
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
13.90

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Exosomal mRNA Urine Test for Detection and Risk Stratification of Human Kidney Transplant Rejection

Johan Skog, Nour K. Younis, Helmut G. Rennke, Areej Alghamdi et al.
7 citations
Kidney International Reports
Renal Transplantation Outcomes and Treatments
13.90
article

An Exosomal mRNA Urine Test for Detection and Risk Stratification of Human Kidney Transplant Rejection

Johan Skog, Nour K. Younis, Helmut G. Rennke, Areej Alghamdi, Reza Abdi, Kurt Franzen, Sonia Kumar, Elliot Hallmark, Jamil Azzi, Anil Chandraker, Ahmad Halawi, Christa Deban, Anis J. Saad, Richard N. Formica, Shuran Xing, Zhabiz Solhjou, Rania El Fekih, John Y. Choi, James F. Markmann, Astrid Weins, Camila Macedo, Siawosh K. Eskandari, James Hurley, Kassem Safa, Leonardo V. Riella, K. D. Cashman, Tamara Merhej, Matt McFaul, Chris Ventura, Brian C. Haynes, Maribel Dagher, Alexandre V Vlassov, Soltan Al Chaar
article en
7 citations

Abstract

Exosomal mRNA gene signatures identified patients with different stages and classes of rejection, including early stage and significant inflammation, enabling improved decision-making and patient management and reducing unnecessary biopsies by 45%. This represents a potential tool for risk stratification based on poor outcomes in patients with positive signatures.

Kidney International ReportsVol. 10(4)
Brigham and Women's Hospital (US), Harvard University (US), Hospital of the University of Pennsylvania (US), Yale University (US), Exosome Diagnostics (United States) (US), Massachusetts General Hospital (US)
Brigham and Women's Hospital, Massachusetts General Hospital, Yale University, University of Pittsburgh
Openalex Percentile: Top 1%
Renal Transplantation Outcomes and Treatments
13.90
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.